Amarin Corp Plcuk (AMRN) Net Margin (QoQ) (2013 - 2026)

Amarin Corp Plcuk (AMRN) Net Margin (QoQ) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2,080.00
Dec 31, 2025 1,309.00
Sep 30, 2025 386.00
Jun 30, 2025 1,792.00
Mar 31, 2025 4,067.00
Dec 31, 2024 -1,861.00
Sep 30, 2024 -6,168.00
Jun 30, 2024 1,987.00
Mar 31, 2024 -987.00
Dec 31, 2023 2,150.00
Sep 30, 2023 -733.00
Jun 30, 2023 -276.00
Mar 31, 2023 -2,009.00
Dec 31, 2022 667.00
Sep 30, 2022 6,836.00
Jun 30, 2022 -4,072.00
Mar 31, 2022 -4,353.00
Dec 31, 2021 1,943.00
Sep 30, 2021 -1,431.00
Jun 30, 2021 620.00